Angel Biotechnology has reported revenues of £3.456m for the peered ended 31 March. Profits fell from £1.9m to £1.2m partly as a result of the expenditure prepare its Cramlington facility for its initial MHRA inspection. The company plans to continue consolidating its businesses in the coming year.
Proactive Investors
Tuesday 5 June 2012
Profits fall at Angel
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment